Immunotherapy with anti-PSMA x anti-CD3 bispecific antibody stimulates potent killing of a human prostate cancer cell line and target mediated T cell activation in monkeys: A potential therapy for prostate cancer

被引：1
|
作者：
Chu, Seung Y.
Pong, Erik W. K.
Rashid, Rumana
Chen, Hsing
Chan, Emily W.
Phung, Sheryl
Endo, Nancy A.
Ardila, Maria C.
Bonzon, Christine
Leung, Irene W. L.
Muchhal, Umesh S.
Moore, Gregory L.
Bernett, Matthew J.
Desjarlais, John R.
Szymkowski, David E.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-5000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5000
引用
收藏
页数：4
相关论文
共 50 条
  • [21] New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy
    Vittore Cereda
    Diane J. Poole
    Claudia Palena
    Sudipto Das
    Tapan K. Bera
    Cinzia Remondo
    James L. Gulley
    Philip M. Arlen
    Junko Yokokawa
    Ira Pastan
    Jeffrey Schlom
    Kwong Y. Tsang
    Cancer Immunology, Immunotherapy, 2010, 59 : 63 - 71
  • [22] New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy
    Cereda, Vittore
    Poole, Diane J.
    Palena, Claudia
    Das, Sudipto
    Bera, Tapan K.
    Remondo, Cinzia
    Gulley, James L.
    Arlen, Philip M.
    Yokokawa, Junko
    Pastan, Ira
    Schlom, Jeffrey
    Tsang, Kwong Y.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (01) : 63 - 71
  • [23] Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer
    C Sanchez
    R Chan
    P Bajgain
    S Rambally
    G Palapattu
    M Mims
    C M Rooney
    A M Leen
    M K Brenner
    J F Vera
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 123 - 131
  • [24] Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer
    Sanchez, C.
    Chan, R.
    Bajgain, P.
    Rambally, S.
    Palapattu, G.
    Mims, M.
    Rooney, C. M.
    Leen, A. M.
    Brenner, M. K.
    Vera, J. F.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (02) : 123 - 131
  • [25] T-cell mediated lysis of prostate cancer cells with a single-chain PSMA/CD3 bispecific antibody construct.
    Elsaesser-Beile, Ursula
    Buehler, Patrick
    Wolf, Philipp
    Katzenwadel, Arndt
    Wetterauer, Ulrich
    TUMOR BIOLOGY, 2006, 27
  • [26] A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
    Frey, Gerhard
    Cugnetti, Ana Paula G.
    Liu, Haizhen
    Xing, Charles
    Wheeler, Christina
    Chang, Hwai Wen
    Boyle, William J.
    Short, Jay M.
    MABS, 2024, 16 (01)
  • [27] 99mTc tricarbonyl labelled single chain anti-PSMA antibody fragment: Evaluation in PSMA positive prostate cancer cell lines
    Nawaz, S.
    Kampmeier, F.
    Mullen, G. E. D.
    Blower, P. J.
    Ballinger, J. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S325 - S325
  • [28] Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
    Montagner, Isabella Monia
    Penna, Alessandro
    Fracasso, Giulio
    Carpanese, Debora
    Dalla Pieta, Anna
    Barbieri, Vito
    Zuccolotto, Gaia
    Rosato, Antonio
    CELLS, 2020, 9 (06)
  • [29] Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo
    Juan Ma
    Tengfei Shang
    Pan Ma
    Xin Sun
    Jin Zhao
    Ximing Sun
    Man Zhang
    Investigational New Drugs, 2019, 37 : 1036 - 1043
  • [30] Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo
    Ma, Juan
    Shang, Tengfei
    Ma, Pan
    Sun, Xin
    Zhao, Jin
    Sun, Ximing
    Zhang, Man
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (05) : 1036 - 1043
12345